2m 2m 2m 2m 2m 2m 2m
Dexcom (DXCM)
NASDAQ
$75.97-$0.38 (-0.50%)
Price as of Jul 13, 2026 8:00 PM EDT- $28.9BMarket Cap
- -10.52%1-Year Change
- Medical DevicesIndustry
Dexcom (DXCM)
$75.97-$0.38 (-0.50%)
DXCM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $76.35 | ||
Change | +$1.39 (+1.85%) | ||
Open | $75.56 | ||
High | $76.42 | ||
Low | $74.58 | ||
Previous Close | $74.96 | ||
Volume | 3,553,999 | ||
30-Day Average Volume | 4,834,857 | ||
1-Week Change | 5.48% | ||
1-Month Change | 1.30% | ||
1-Year Change | -10.52% | ||
3-Year Change | -43.01% | ||
5-Year Change | -31.58% | ||
Fundamentals | |||
Shares Outstanding | 385.9M | ||
Total Assets | $6.6B | ||
Market Cap | $28.9B | ||
Enterprise Value | $29.0B | ||
Period: QTR TTM FY | |||
Revenue | $1.2B | ||
Net Income | $199.5M | ||
Free Cash Flow | $449.0M | ||
EBIT | $271.6M | ||
EBITDA | $338.7M | ||
Net Working Capital | $2.1B | ||
EPS | $0.51 | ||
Enterprise Value/EBITDA | 86 | ||
Enterprise Value/Revenue | 24 | ||
P/B | 10 | ||
P/E | 147 | ||
PEG | -6 | ||
Price/Free Cash Flow | 64 | ||
Price/Operating Cash Flow | 55 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 4 : 1 | ||
Last Split Date | 06/13/2022 | ||
Earnings & Revenue